Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Korea, republic of
  4. Korea Stock Exchange
  5. Sejong Medical Co., Ltd.
  6. News
  7. Summary
    A258830   KR7258830009

SEJONG MEDICAL CO., LTD.

(A258830)
  Report
SummaryChartsNewsCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Sejong Medical Co., Ltd. announced that it expects to receive KRW 32.49815256 billion in funding from Time Investment Co., Ltd, and other investors

07/23/2021 EDT

Sejong Medical Co., Ltd. announced a private placement of series 1 non-guaranteed private equity convertible bonds with bearer type interest part for gross proceeds of KRW 10,000,000,000, series 2 non-guaranteed private convertible bonds with bearer type interest part for gross proceeds of KRW 10,000,000,000 and 1,355,548 common shares at a price of KRW 9,220 per share for gross proceeds of KRW 12,498,152,560, for aggregate gross proceeds of KRW 32,498,152,560 on July 23, 2021. The transaction will include participation from new investors K1 Bio Combination 1 for series 1 bonds, H Bio Association 1 for series 2 bonds, and Time Investment Co., Ltd for common shares. The common shares have a face value of KRW 500 per share. The series 1 and series 2 bonds carry yield to maturity rate of 2%, fixed interest rate of 2%, will mature on September 17, 2024, and are fully convertible into 970,591 common shares, representing 14.32% stake in the company, at a fixed conversion price of KRW 10,303 per share, from September 17, 2022 to August 17, 2024. The company will issue securities through 3rd party allocation increase method. The transaction has been approved by board of directors of the company. The payment date for bonds is September 17, 2021 and payment date for common shares is September 10, 2021. The shares to be issued in the transaction will be subject to a lock-up period of 1 year.


© S&P Capital IQ 2021
All news about SEJONG MEDICAL CO., LTD.
09/17Sejong Medical Co., Ltd. announced that it has received KRW 32.49815256 billion in fund..
CI
07/23Sejong Medical Co., Ltd. announced that it expects to receive KRW 32.49815256 billion i..
CI
2020Sejong Medical Co., Ltd. agreed to acquire 29.4% stake in Yozma BMTECH CO,LTD. for KRW ..
CI
2020Tranche Update on Sejong Medical Co., Ltd.'s Equity Buyback Plan announced on March 30,..
CI
2020Sejong Medical Co., Ltd.'s Equity Buyback announced on March 30, 2020, has closed with ..
CI
2020Sejong Medical Co., Ltd. announces an Equity Buyback for 100,000 shares.
CI
2020Sejong Medical Co., Ltd. authorizes a Buyback Plan.
CI
2020Tranche Update on Sejong Medical Co., Ltd.'s Equity Buyback Plan announced on March 6, ..
CI
2020Sejong Medical Co., Ltd.'s Equity Buyback announced on March 6, 2020, has closed with 1..
CI
2020Sejong Medical Co., Ltd.'s Equity Buyback Plan Extended till June 6, 2020.
CI
More news
Financials
Sales 2020 15 098 M 12,8 M 12,8 M
Net income 2020 470 M 0,40 M 0,40 M
Net cash 2020 8 581 M 7,28 M 7,28 M
P/E ratio 2020 190x
Yield 2020 0,73%
Capitalization 274 B 233 M 232 M
EV / Sales 2019 1,97x
EV / Sales 2020 5,27x
Nbr of Employees 107
Free-Float 8,67%
Chart SEJONG MEDICAL CO., LTD.
Duration : Period :
Sejong Medical Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
Hyun-Guk Jung Co-Chief Executive Officer, Director & Head-Sales
Sung-Hwan Cho Co-Chief Executive Officer & Director
Yoon-Ho Jung Vice President, Head-Research & Development
Yoon-Deok Lee Independent Director
Sung-Min Ko Director & Head-Production